Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Cancer Lett. 2024 Mar 1;584:216608. doi: 10.1016/j.canlet.2024.216608. Epub 2024 Jan 9.
Cancer Lett. 2024.
PMID: 38199587
Free article.
Patient-derived tumor organoids with p53 mutations, and not wild-type p53, are sensitive to synergistic combination PARP inhibitor treatment.
Madorsky Rowdo FP, Xiao G, Khramtsova GF, Nguyen J, Olopade OI, Martini R, Stonaker B, Boateng R, Oppong JK, Adjei EK, Awuah B, Kyei I, Aitpillah FS, Adinku MO, Ankomah K, Osei-Bonsu EB, Gyan KK, Altorki NK, Cheng E, Ginter PS, Hoda S, Newman L, Elemento O, Davis MB, Martin ML, Bargonetti J.
Madorsky Rowdo FP, et al.
bioRxiv [Preprint]. 2023 Jun 22:2023.06.22.544406. doi: 10.1101/2023.06.22.544406.
bioRxiv. 2023.
PMID: 38076873
Free PMC article.
Updated.
Preprint.
Item in Clipboard
Epigenetic inhibitors eliminate senescent melanoma BRAFV600E cells that survive long‑term BRAF inhibition.
Madorsky Rowdo FP, Barón A, Gallagher SJ, Hersey P, Emran AA, Von Euw EM, Barrio MM, Mordoh J.
Madorsky Rowdo FP, et al.
Int J Oncol. 2020 Jun;56(6):1429-1441. doi: 10.3892/ijo.2020.5031. Epub 2020 Mar 30.
Int J Oncol. 2020.
PMID: 32236593
Free PMC article.
Item in Clipboard
In vitro long-term treatment with MAPK inhibitors induces melanoma cells with resistance plasticity to inhibitors while retaining sensitivity to CD8 T cells.
Madorsky Rowdo FP, Barón A, von Euw EM, Mordoh J.
Madorsky Rowdo FP, et al.
Oncol Rep. 2017 Mar;37(3):1367-1378. doi: 10.3892/or.2017.5363. Epub 2017 Jan 13.
Oncol Rep. 2017.
PMID: 28098866
Free PMC article.
Item in Clipboard
Immunotherapy in Cancer: A Combat between Tumors and the Immune System; You Win Some, You Lose Some.
Madorsky Rowdo FP, Baron A, Urrutia M, Mordoh J.
Madorsky Rowdo FP, et al.
Front Immunol. 2015 Mar 26;6:127. doi: 10.3389/fimmu.2015.00127. eCollection 2015.
Front Immunol. 2015.
PMID: 25859247
Free PMC article.
Review.
Item in Clipboard
High lipid content of irradiated human melanoma cells does not affect cytokine-matured dendritic cell function.
Pizzurro GA, Madorsky Rowdo FP, Pujol-Lereis LM, Quesada-Allué LA, Copati AM, Roberti MP, Teillaud JL, Levy EM, Barrio MM, Mordoh J.
Pizzurro GA, et al. Among authors: madorsky rowdo fp.
Cancer Immunol Immunother. 2013 Jan;62(1):3-15. doi: 10.1007/s00262-012-1295-4. Epub 2012 Jun 22.
Cancer Immunol Immunother. 2013.
PMID: 22722447
Free PMC article.
Item in Clipboard
Melanoma vaccines and modulation of the immune system in the clinical setting: building from new realities.
Madorsky-Rowdo FP, Lacreu ML, Mordoh J.
Madorsky-Rowdo FP, et al.
Front Immunol. 2012 May 4;3:103. doi: 10.3389/fimmu.2012.00103. eCollection 2012.
Front Immunol. 2012.
PMID: 22566975
Free PMC article.
Item in Clipboard
Cite
Cite